| Molecular |
ABL1 Kinase Domain Mutation Analysis
|
RT-PCR and sequencing of the BCR-ABL1 fusion transcript for qualitative detection of mutations associated with imatinib resistance
|
View
|
| Molecular |
B & T Cell Gene Rearrangement
|
PCR for detection of clonal IgH, Ig kappa, and T cell receptor gene gamma gene rearragements.
|
View
|
| Molecular |
B-Cell Gene Rearrangement
|
Detection of clonal IgH and Ig kappa gene rearragements by PCR of IgH framework regions 1, 2, 3 and joining regions, Ig kappa FR3 and Jk regions.
|
View
|
| Molecular |
BCL1 Translocation, t(11;14)
|
PCR and detection of IGH-CCND1 t(11;14) chromosomal translocation.
|
View
|
| Molecular |
BCL2 Translocation, t(14;18)
|
Real-time PCR for qualitative detection of IGH/BCL2, t(14;18) translocations involving the mbr, mcr, and icr breakpoint regions.
|
View
|
| Molecular |
BCR-ABL1 Translocation, t(9;22) – quantitative
|
Real-time PCR for detection of t(9;22) BCR/ABL fusion transcripts that result in p190 (E1) or p210 (E13, E14) fusion proteins. Analytical sensitivity is 1 tumor cell in 100,000 normal cells. Log reduction score is reported.
|
View
|
| Molecular |
BRAF Mutation Analysis
|
Bi-directional sequencing of exon 15 of the BRAF gene, which includes qualitative detection of V600 mutations E, K, D, and others, plus other significant exon 15 mutations. For solid tumors, tumor enrichment is performed before extraction.
|
View
|
| Molecular |
CEBPA
|
DNA sequencing to detect single and double mutations within the CEBPA coding region from blood or Bone Marrow specimens.
|
View
|
| Molecular |
EGFR Mutation Analysis
|
Bi-directional sequencing of exons 18-21 of the EGFR gene for detection of EGFR-activating mutations and TKI resistance mutations in these exons. Tumor enrichment is performed before extraction.
|
View
|
| Molecular |
IgVH Mutation Analysis
|
RT-PCR and bi-directional sequencing of the variable region of the immunoglobulin heavy chain for detection of mutation from germline sequence. The mutated VH gene family is identified in positive reports (>3% sequence deviation). Mutation may not be detectable in specimens containing <10% clonal B-cells.
|
View
|
| Molecular |
JAK2 Exon 12 Mutation Analysis
|
Qualitative detection of four exon 12 mutations in JAK2 by real-time PCR. Test is available separately or as part of MPN Reflex Panel.
|
View
|
| Molecular |
KRAS & BRAF Mutation Analysis
|
Concurrent analysis of KRAS and BRAF gene regions including KRAS exons 1 and 2 (with mutation detection in codons 12, 13, and 61) and BRAF exon 15 to detect V600 mutations and more. Tumor enrichment is performed before extraction.
|
View
|
| Molecular |
KRAS Mutation Analysis
|
Bi-directional sequencing of exons 1 and 2 of the KRAS gene, which includes detection of mutations in codons 12, 13, and 61. Tumor enrichment is performed before extraction.
|
View
|
| Molecular |
MPL Mutation Analysis
|
Qualitative detection of the W515 mutations by real-time PCR. Test is available separately or as part of MPN Reflex Panel.
|
View
|
| Molecular |
MPN Reflex Panel
|
3-step reflex panel with qualitative testing for JAK2 V617F mutation, then JAK2 exon 12 mutations, then MPL W515 mutations. Test components are available separately.
|
View
|
| Molecular |
PML-RARA Translocation, t(15;17)
|
Qualitative detection of the three variant translocations with t(15;17) by reverse transcription followed by real-time PCR. The PML/RARA fusion types are bcr1 (long), bcr2 (variable), and bcr3 (short).
|
View
|
| Molecular |
T-Cell Gene Rearrangement
|
Detection of clonal T-cell receptor gamma gene rearrangements by PCR of variable and joining regions.
|
View
|